In conclusion, our study aims to analyze the immune microenvironment and tumor heterogeneity in OS using single-cell sequencing data, identifying distinct differentiation trajectories of CD8+ T cells in different individuals, and conducting a thorough evaluation of CD8+ T cells, which holds promise in shedding light on new avenues for OS immunotherapy. This evidence concerns the gene CD8A and neoplasm.